1. Carbazole scaffolds in cancer therapy: a review from 2012 to 2018. (1st January 2019) Authors: Issa, Samar; Prandina, Anthony; Bedel, Nicolas; Rongved, Pål; Yous, Saïd; Le Borgne, Marc; Bouaziz, Zouhair Journal: Journal of enzyme inhibition and medicinal chemistry Issue: Volume 34:Number 1(2019) Page Start: 1321 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. NCOG-05. IMPACT OF ADDITIONAL RITUXIMAB TO STANDARD THERAPY ON COGNITIVE PERFORMANCES IN PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA PATIENTS. (11th November 2019) Authors: van der Meulen, Matthijs; Dirven, Linda; Habets, Esther; Bakunina, Katerina; Taphoorn, Martin; van den Bent, Martin; Issa, Samar; Doorduijn, Jeanette K; Bromberg, Jacoline E C Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi159 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Primary idiopathic CNS non-amyloidogenic light chain deposition disease complicated by treatment-resistant focal seizure disorder. (January 2019) Authors: Grainger, Brian T.; Issa, Samar; Anderson, Neil E. Journal: Journal of clinical neuroscience Issue: Volume 59(2019) Page Start: 313 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Rituximab in patients with primary CNS lymphoma (HOVON 105/ALLG NHL 24): a randomised, open-label, phase 3 intergroup study. Issue 2 (February 2019) Authors: Bromberg, Jacoline E C; Issa, Samar; Bakunina, Katerina; Minnema, Monique C; Seute, Tatjana; Durian, Marc; Cull, Gavin; Schouten, Harry C; Stevens, Wendy B C; Zijlstra, Josee M; Baars, Joke W; Nijland, Marcel; Mason, Kylie D; Beeker, Aart; van den Bent, Martin J; Beijert, Max; Gonzales, Michael; ... Journal: Lancet oncology Issue: Volume 20:Issue 2(2019) Page Start: 216 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗